NotSoWise Posted December 4, 2021 Posted December 4, 2021 (edited) 9 hours ago, Spekulatius said: Added a bit to various positions - SWMAY, VNT, PSMT, PINS. Spek, out of curiosity checked your picks and VNT got me to read more about it. I did some limited reading. Are you looking at it as short term thing with multiple rebound from low PE? As a long term hold, there might be some concerns about their revenue lines plus some 3x debt, which will limit what they could do over the next 2-3 years? DBR acquisition was not cheap. Also Danaher spins-off below average businesses to what they keep, I guess Fortive did the same. Once the multiple is up, there would be less reasons to hold. Edited December 4, 2021 by NotSoWise
lnofeisone Posted December 6, 2021 Posted December 6, 2021 On 10/18/2021 at 6:31 PM, lnofeisone said: Started to buy more serious UNG put positions. Trash security in an overextended natural gas market. I'm also using the cover of the economist as my "do the opposite" proxy. Selling my puts. Accidental multi-bagger.
Red Lion Posted December 6, 2021 Posted December 6, 2021 Added to my APO, which is very close to a max position allocation for me.
Red Lion Posted December 9, 2021 Posted December 9, 2021 (edited) Recycled proceeds from SAM and SFTBY into BRKB and harvested a small short term loss. Several of you have convinced that there are better ways to play the SAM game through options, and it's certainly not screamingly cheap at these prices, although I do believe in the long term future of this business and they seem to earn better ROIC up until this most recent hard seltzer fiasco. SFTBY I continue to want some exposure to, and this may be very poor timing. Also added a few more shares of APO after rolling my 1/20/23 APO puts to a higher strike price for a credit. Edited December 9, 2021 by RedLion
bennycx Posted December 10, 2021 Posted December 10, 2021 On 11/15/2021 at 11:26 PM, irnovo said: I'll suggest reading two writeups on VIC, https://www.valueinvestorsclub.com/ For me, I am mostly looking at bigger picture and downside protection. Plasma protein market will continue to grow for the foreseeable future. GRFS is in plasma protein oligopoly. Debt is being used to acquire smaller players in the market. The cost of debt is low, indicating no worries that company will not be able to debt/interest. I don't see a scenario where rev does not grow or margins suppress. The risk is that gene editing tech (CRISPR etc) makes plasma protein therapies obsolete, but that is really far in my opinion. Recent weakness in share price is due to debt and dividend cut. My time horizon and expectation is a double in 5 years. what do you think of the strategic investment from GIC where they are using high cost "debt" although longer duration to repay back low cost debt?
Gregmal Posted December 13, 2021 Posted December 13, 2021 Larger than normal sized starts in Nintendo and T, also added to MSGS and AAPL puts
rkbabang Posted December 13, 2021 Posted December 13, 2021 (edited) Sold 10% of AAPL and purchased out of the money AAPL puts. Also some way out of the money PTON puts. (see my post in the Peloton thread). Edited December 13, 2021 by rkbabang
boilermaker75 Posted December 14, 2021 Posted December 14, 2021 BTC my 70-strike December MSGE puts for $5.30 and STO 70-strike January MSGE puts for $7.10.
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now